STEM
Chris Doel has a diverse and extensive work experience in the pharmaceutical and healthcare industry. Chris has held various leadership roles in companies such as STEM, THREAD, IQVIA, Medidata Solutions, PPD, ICON Clinical Research, and Phase Forward. These roles have involved responsibilities in sales, business development, and strategic accounts, with a focus on driving innovation and providing solutions to improve patient outcomes. Chris has demonstrated expertise in conducting decentralized and hybrid clinical trials, leveraging technology and data analytics to accelerate drug development and commercialization processes. Overall, Chris Doel's work experience showcases their strong industry knowledge and ability to build and lead successful teams in the healthcare sector.
Chris Doel completed a Bachelor of Science degree in Chemistry at the University of Southampton.
STEM
STEM is part of Inizio Advisory, a trusted advisor for pharmaceutical, life science and healthcare companies at every stage of the product and patient journey. Through Advisory’s data driven approach and connected intelligence and solutions, Inizio Advisory helps accelerate clinical and commercial success, creating long term value for clients and their patients. Since 2007, STEM has been helping life science companies optimize the commercial performance by measuring the alignment between their brand strategy and execution at every stage of the product stage of the product lifecycle. We do this through our objective industry insights, robust benchmarking data, and a proven methodology, helping clients to improve return on investment, drive greater customer engagement, accelerate their brands performance and ensure world-class medicines reach the right patients.